OUR BLOG
Discover sickle cell disease stories and updates from SCAGO
News
Our latest post
SCAGO
Sep 26, 2024
Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY®
The Sickle Cell Awareness Group of Ontario (SCAGO) is pleased with the news of CASGEVY (Exagamglogene Autotemcel) receiving marketing authorization for the treatment of Sickle Cell and Thalassemia disorders in Canada.
Articles
Discover our other posts
Explore our articles to know the best behavior about alimentation and well-being.
Quick Links
Contact
Address: 330-5109 Steeles Ave W.
North York, ON , M9L 2Y8
Phone: GTA: 416-745-4267
Email: info@sicklecellanemia.ca
© SCAGO - All Rights Reserved -Disclaimer - Charitable Registration #: 83332 0872 RR 0001